| Followers | 22 |
| Posts | 2401 |
| Boards Moderated | 1 |
| Alias Born | 09/27/2020 |
Tuesday, September 27, 2022 8:25:31 PM
And the theft will continue after the RS where issued shares are reduced by factor of 25 but authorized shares are untouched. Some investors already down 95% will continue to pour money into IBIO. Management will continue milking this cow for their bloated salaries until shareholders vote them out. Will be too late at that point, because as redspeed stated, no one is coming to the rescue of IBIO.
Sad, but true.
Grand larceny occurred here
Sad, but true.
Recent IBIO News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/29/2026 01:11:36 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 04/17/2026 09:13:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/08/2026 01:00:47 PM
- iBio Received Regulatory Clearance to Initiate Its Phase 1 Clinical Trial of IBIO-600 in Australia • GlobeNewswire Inc. • 04/08/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/27/2026 08:05:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/23/2026 11:31:15 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/23/2026 11:30:09 AM
- iBio to Provide an Update on Cardiopulmonary Program Targeting Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction (PH-HFpEF) • GlobeNewswire Inc. • 03/16/2026 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/09/2026 11:04:38 AM
- iBio Reports Preclinical Body Composition Data from Obese Non-Human Primates Treated with IBIO-610, a Potential First-in-Class Treatment for Fat-Selective Weight Loss • GlobeNewswire Inc. • 03/09/2026 11:00:00 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/09/2026 04:15:16 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/06/2026 10:25:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2026 09:49:58 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 02/27/2026 09:23:59 PM
- iBio to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 02/24/2026 12:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/17/2026 11:19:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/10/2026 09:16:39 PM
- iBio Reports Q2 Fiscal Year 2026 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 02/10/2026 09:05:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/09/2026 10:29:54 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/30/2026 09:10:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2026 11:15:07 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 01/30/2026 02:29:29 AM

